Latest News Pulmonx to Report Second Quarter 2023 Financial Results on Businessfortnight

REDWOOD CITY, Calif., July 19, 2023 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2023 after the close of trading on Wednesday, August 2, 2023. Company management…Read More